NCT03929445

Brief Summary

This study aims to compare using bougie as an assistant for endotracheal intubation through Air-Q and Fastrach intubating laryngeal mask devices when blind intubation fails as attempt to increase its success rate.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2017

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2017

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2018

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

November 8, 2018

Completed
6 months until next milestone

First Posted

Study publicly available on registry

April 26, 2019

Completed
Last Updated

April 30, 2019

Status Verified

March 1, 2019

Enrollment Period

6 months

First QC Date

November 8, 2018

Last Update Submit

April 26, 2019

Conditions

Keywords

BougieAir QFastrach

Outcome Measures

Primary Outcomes (2)

  • success rate of endotracheal intubation on the first, second and third attempts in both devices Air-Q and fastrach

    If the blind intubation is failed through Air Q or Fastrack Intubating laryngeal mask the investigator will use gum elastic bougie to facilitate introducing an endotracheal tube estimation of success rate of endotracheal intubation on the first, second and third attempts

    180 seconds after anethesia induction

  • The time needed for devices insertion (Air Q and Fastrach Intubating Laryngeal mask)

    1. Air Q and Fastrach Intubating laryngeal mask insertion time in seconds will be measured (device time). 2. Endotracheal tube (ETT) insertion time will be measured ( ETT time). 3. Total insertion time will be estimated (Device Time + ETT Time )

    !80 seconds after anesthesia induction

Secondary Outcomes (1)

  • Incidence of adverse events

    Intraoperative and in the first 48 postoperative hours

Study Arms (2)

AIR-Q group

ACTIVE COMPARATOR

the group which selected randomly to try AIR-Q device

Device: Endotracheal tube introducers

I-LMA group

ACTIVE COMPARATOR

the group which selected randomly to try I-LMA device

Device: Endotracheal tube introducers

Interventions

Endotracheal tube introducers (gum elastic bougie) for emergency intubation The endotracheal tube introducer (ETI) is an effective and inexpensive adjunct to difficult airway management that is easy to use. ETI is solid introducer 60-70 cm long with a 35 - 40 distally angulated (Coude) tip. They are easy to use, widely available, and have been used as adjuncts to difficult direct laryngoscopy for many decades. The gum elastic bougie is usually guided by tactile clicks as the device passes the cartilage rings of the trachea. After Supraglottic devices are removed, an ETT can subsequently be railroaded over the bougie.

Also known as: The Gum Elastic Bougie
AIR-Q groupI-LMA group

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient aged \>18 years old.
  • Gender both male and female.
  • Patients are ASA I (American Society of Anesthesiologists' physical status Grade I) normal healthy patients or ASA II patients with mild systemic disease and no functional limitations

You may not qualify if:

  • Any disorder of the cardiovascular, pulmonary, hepatic, renal, or gastrointestinal systems known from history or general examination.
  • Patients with unstable cervical spine
  • Any medical disease that may affect airway as Rheumatoid arthritis.
  • Patient refusal to participate in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ghada A.Kamhawy

Cairo, 12311, Egypt

Location

Study Officials

  • Ghada A. Kamhawy, Lecturer

    Suez Canal University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical professor

Study Record Dates

First Submitted

November 8, 2018

First Posted

April 26, 2019

Study Start

January 1, 2017

Primary Completion

July 1, 2017

Study Completion

November 1, 2018

Last Updated

April 30, 2019

Record last verified: 2019-03

Locations